Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-05-16 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +1,875 $0.00 $0 7,033
2016-05-16 Thomsen Jillian B. SVP & Chief Accounting Officer Returned to the company · Restricted Stock Unit −1,875 18,750
2016-04-25 Lingnau Lutz Director Exercise or conversion +15,000 $8.37 $126K 31,450
2016-04-25 Lingnau Lutz Director Sale −15,000 $16.27 $244K 16,450
2016-04-25 Lingnau Lutz Director Exercise or conversion · Stock Option −15,000 0
2016-03-09 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +15,000 $6.65 $100K 20,158
2016-03-09 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −15,000 $11.79 $177K 5,158
2016-03-09 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −15,000 0
2016-02-17 Gergel Ivan P. SVP & Chief Medical Officer Sale −556 $11.92 $7K 694
2016-02-17 Nicholson John SVP & Chief Financial Officer Sale −963 $11.92 $11K 76,319
2016-02-17 ROBIN HOWARD W President & CEO Sale −2,147 $11.92 $26K 13,478
2016-02-17 Doberstein Stephen K SVP & Chief Scientific Officer Sale −390 $11.92 $5K 485
2016-02-17 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −716 $11.92 $9K 5,158
2016-02-17 Labrucherie Gil M SVP & General Counsel Sale −827 $11.92 $10K 6,590
2016-02-17 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −963 $11.92 $11K 5,803
2016-02-16 Gergel Ivan P. SVP & Chief Medical Officer Exercise or conversion +1,250 $0.00 $0 1,250
2016-02-16 Gergel Ivan P. SVP & Chief Medical Officer Returned to the company · Restricted Stock Unit −1,250 13,750
2016-02-16 Nicholson John SVP & Chief Financial Officer Exercise or conversion +2,166 $0.00 $0 77,282
2016-02-16 Nicholson John SVP & Chief Financial Officer Returned to the company · Restricted Stock Unit −2,166 23,834
2016-02-16 ROBIN HOWARD W President & CEO Exercise or conversion +5,625 $0.00 $1 15,625

Page 53 of 55 · 1,088 trades